0 Members and 1 Guest are viewing this topic.
And can’t we all use some great news at this point? Pfizer’s preliminary studies against COVID-19 variants in the UK and South Africa show that their vaccine remains effective against all of them. That will come as a great relief as nations struggle to roll out vaccines to stem the retransmission tide, and it would also suggest that other mRNA vaccines would offer similar protection:[/url]QuoteMost of the COVID-19 vaccines being rolled out around the world train the body to recognize that spike protein and fight it. Pfizer teamed with researchers from the University of Texas Medical Branch in Galveston for laboratory tests to see if the mutation affected its vaccine’s ability to do so.They used blood samples from 20 people who received the vaccine, made by Pfizer and its German partner BioNTech, during a large study of the shots. Antibodies from those vaccine recipients successfully fended off the virus in lab dishes, according to the study posted late Thursday on an online site for researchers.
Most of the COVID-19 vaccines being rolled out around the world train the body to recognize that spike protein and fight it. Pfizer teamed with researchers from the University of Texas Medical Branch in Galveston for laboratory tests to see if the mutation affected its vaccine’s ability to do so.They used blood samples from 20 people who received the vaccine, made by Pfizer and its German partner BioNTech, during a large study of the shots. Antibodies from those vaccine recipients successfully fended off the virus in lab dishes, according to the study posted late Thursday on an online site for researchers.
Author
Topic: Great News: Pfizer Says Vaccine Works Against UK, South Africa Mutations (Read 269 times)
